MgSO4 is one of 131 small molecule programs targeting Encephalopathy. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
230 competitors in Cesarean Section
MgSO4
Pitocin
Dynastat
Ancef
Nubain
Intrathecal Morphine
Sufenta
Imdur
Bactroban
Imitrex
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details